Evidence map›Paper›PMID 26109319›Full record

ArticleJournal of the American Society of Nephrology : JASN2016

Retinoic Acid Signaling Coordinates Macrophage-Dependent Injury and Repair after AKI.

Takuto Chiba, Nataliya I Skrypnyk, Lauren Brilli Skvarca, Radostin Penchev, Ke Xin Zhang, Elizabeth R Rochon, Jessica L Fall, Paisit Paueksakon, Haichun Yang, Catherine E Alford and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Vitamin A and retinoid signaling in the kidneys.Pharmacology & therapeutics · 2023
    Review
  14. Review
  15. Article
  16. Liposoluble vitamins A and E in kidney disease.World journal of nephrology · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Takuto ChibaDivision of Nephrology, Department of Medicine, Departments of Cell and Developmental Biology, and.
Nataliya I SkrypnykDivision of Nephrology, Department of Medicine.
Lauren Brilli SkvarcaDepartments of Developmental Biology.
Radostin PenchevDivision of Nephrology, Department of Medicine.
Ke Xin ZhangDivision of Nephrology, Department of Medicine.
Elizabeth R RochonBiological Sciences.
Jessica L FallDepartments of Developmental Biology.
Paisit PaueksakonPathology, Vanderbilt University, Nashville, Tennessee;
Haichun YangPathology, Vanderbilt University, Nashville, Tennessee;
Catherine E AlfordDepartment of Pathology and Laboratory Medicine, Veteran Affairs Tennessee Valley Health Authority, Nashville, Tennessee; and.
Beth L RomanHuman Genetics, and.
Ming-Zhi ZhangDivision of Nephrology, Department of Medicine.
Raymond HarrisDivision of Nephrology, Department of Medicine.
Neil A HukriedeDepartments of Developmental Biology, Center for Critical Care Nephrology, University of Pittsburgh, Pittsburgh, Pennsylvania mark.de.caestecker@vanderbilt.edu hukriede@pitt.edu.
Mark P de CaesteckerDivision of Nephrology, Department of Medicine, Departments of Cell and Developmental Biology, and mark.de.caestecker@vanderbilt.edu hukriede@pitt.edu.
Vanderbilt University · USInstitute of Human Genetics · PLTennessee Valley Authority · USUniversity of Pittsburgh · US

Funding

TRANSPORT EFFECTS OF ARACHIDONATE METABOLITES IN PERFUSED TUBULEP01DK038226 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BROWN, NANCY J. · 1986 to 2015
$22.1M
Single Nephron and MetabolomicsP30DK079307 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLEYMAN, THOMAS R · 2008 to 2022
$13.4M
The Role of the EGF Receptor in Acute and Chronic Renal InjuryR01DK051265 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RAYMOND C. HARRIS, Mingzhi Zhang · 1997 to 2026
$10.1M
The role of the innate immune cell cyclooxygenase/prostaglandin system in blood pressureregulationR01DK062794 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RAYMOND C. HARRIS, Mingzhi Zhang · 2003 to 2026
$9.4M
The Role of renal macrophages in recovery from renal injuryR01DK095785 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RAYMOND C. HARRIS, Mingzhi Zhang · 2013 to 2026
$6.7M
RESOLUTION OF GLOMERULOSCLEROSISR01DK056942 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FOGO, AGNES B. · 2001 to 2021
$4.9M
Regulation of Renal Progenitor Cells in Regenerating KidneysR01DK069403 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUKRIEDE, NEIL A · 2006 to 2020
$4.8M
Vanderbilt Student Research Training ProgramT35DK007383 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI William Heerman · 1986 to 2026
$4.1M
Utilizing Small Molecule Screens to Delineate Embryonic Signaling MechanismsR01HD053287 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUKRIEDE, NEIL A, TSANG, MICHAEL WAIKOK · 2007 to 2016
$3.1M
Small Molecule-Mediated Augmentation of Kidney RegenerationRC4DK090770 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUKRIEDE, NEIL A · 2010 to 2010
$2.8M
BMP Signaling and Pulmonary VasoreactivityR01HL093057 · NHLBI · VANDERBILT UNIVERSITY · PI DE CAESTECKER, MARK P. · 2010 to 2013
$1.5M
Elucidating the Mechanisms of Kidney Regeneration and Therapeutic AugmentationF30DK101143 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SKVARCA, LAUREN BRILLI · 2013 to 2016
$185k
NHLBI NIH HHS 1R01-HL093057NHLBI NIH HHS R01 HL093057NICHD NIH HHS 2R01-HD053287NICHD NIH HHS R01 HD053287NIDDK NIH HHS 1P30-DK079307NIDDK NIH HHS 1RC4-DK090770NIDDK NIH HHS 1RC-4DK090770NIDDK NIH HHS 2R01-DK069403NIDDK NIH HHS DK38226NIDDK NIH HHS DK51265NIDDK NIH HHS DK62794NIDDK NIH HHS DK95785NIDDK NIH HHS F30 DK101143NIDDK NIH HHS P01 DK038226NIDDK NIH HHS P30 DK079307NIDDK NIH HHS P30-DK079307NIDDK NIH HHS R01 DK051265NIDDK NIH HHS R01 DK056942NIDDK NIH HHS R01 DK062794NIDDK NIH HHS R01 DK069403NIDDK NIH HHS R01 DK095785NIDDK NIH HHS RC4 DK090770NIDDK NIH HHS T35 DK007383
6 · The paper itself

Abstract

Retinoic acid (RA) has been used therapeutically to reduce injury and fibrosis in models of AKI, but little is known about the regulation of this pathway and what role it has in regulating injury and repair after AKI. In these studies, we show that RA signaling is activated in mouse and zebrafish models of AKI, and that these responses limit the extent of injury and promote normal repair. These effects were mediated through a novel mechanism by which RA signaling coordinated the dynamic equilibrium of inflammatory M1 spectrum versus alternatively activated M2 spectrum macrophages. Our data suggest that locally synthesized RA represses proinflammatory macrophages, thereby reducing macrophage-dependent injury post-AKI, and activates RA signaling in injured tubular epithelium, which in turn promotes alternatively activated M2 spectrum macrophages. Because RA signaling has an essential role in kidney development but is repressed in the adult, these findings provide evidence of an embryonic signaling pathway that is reactivated after AKI and involved in reducing injury and enhancing repair.

Indexed as

Signal TransductionAcute Kidney InjuryAnimalsMacrophagesMaleMiceMice, Inbred BALB CTretinoinTretinoinacute renal failuremacrophagesrenal injuryrenal proximal tubule cellsignalingtubular epithelium

Identifiers

PMID26109319
PMCPMC4731115
OpenAlexW2098070914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.